Creative Edge

Phenylalanine Market Drivers An increase in the prevalence of anxiety and depression is driving up anti-depressant usage, which is driving up the global  Phenylalanine Market . According to World Health Organization (WHO) figures, over 300 million people of all ages suffered from depression in 2017, with about 800,000 individuals dying by suicide as a result of anxiety disorders and depression as the primary cause. Furthermore, the National Institute of Mental Health (NIMH) estimates that in 2016, 10.3 million adults in the United States (4.3 percent of all adults in the United States) aged 18 and older experienced at least one major depressive episode with significant disability.  According to the same source, the prevalence of major depressive disorder was higher in adult females (8.5 percent) than in males (4.8 percent ). Furthermore, the age group 18-25 had the highest rate of adults suffering from a major depressive episode (10.9 percent ). The National Institute of Menta...